Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06040242

Arrhythmogenic Activity During Exercise in ARVC Patients

Current guidelines advocate that ARVC patients, typically young and active individuals with a significant history of competitive endurance sports, cease endurance training in favour of activities with low cardiac burden such as bowling and golf. Empirically, it is often suggested that heart rate during exercise should not exceed 100-120 bpm in these patients, but these guidelines are arbitrary and not scientifically based. In practice, it is estimated that up to 50% of patients do not comply with these recommendations .

Adequate quantification of the arrhythmogenic burden, defined as premature ventricular beats in proportion to all heart beats in each period of time, and cardiac load (defined as stroke volume for volume load and systolic blood pressure for pressure load) experienced by ARVC patients when performing different types of physical exercise would be a first step towards designing a safe and effective intervention so that these patients can profit from an active life style.

This study therefore aims to quantify and describe the arrhythmogenic burden and cardiac load experienced by patients with ARVC while performing different physical exercise over a range of intensities - all strictly within the range currently recommended by different cardiological societies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

14 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich

Zurich, Canton of Zurich, 8092, Switzerland

Location status: Recruiting

Location contact

Fernando G Beltrami, PhD

CONTACT

[email protected]

About this study

In this study, ARVC patients with different genotypes will perform a series of different physical activities, including treadmill walking, cycling at different intensities, biceps curls and loaded squats while undergoing extensive cardiovascular monitoring.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Definitive ARVC diagnosis according to the modified 2010 ARVC Task Force Criteria
  • Pathogenic / likely pathogenic variant in one of the following desmosomal genes: plakophilin-2 (PKP-2), desmoglein-2 (DSG-2) or desmoplakin (DSP) or gene-elusive definite ARVC (i.e., genetic test performed but no pathogenic / likely pathogenic variant found)
  • Control group: diagnosed ischemic heart disease with ejection fraction above 35%
  • Agreement with responsible primary cardiologist that study participation is not considered beyond acceptable levels of physical activity for this particular patient
  • No history of exercise-induced syncope in the 6 months prior to study participation
  • No history of sudden cardiac arrest in the 6 months prior to study participation
  • In patients who suffered from sudden cardiac arrest/arrhythmic syncope, only those having an implantable cardioverter-defibrillator (ICD) and being under beta-blockers/antiarrhythmic drugs are eligible for study inclusion
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Age: > 14 years
  • Body-Mass-Index (BMI): 18.5 - 39.9 kg・m-2
  • Willing to adhere to the following study rules:
  • No intense exercise 48h prior to testing
  • No exercise 24h prior to testing
  • Sleep at least 7h the two nights before testing On test day
  • No caffeinated food or drink before testing on test day
  • No alcohol before testing on test day
  • Fully compliant with normal medication regimen including beta-blockers and antiarrhythmic medication

Exclusion criteria

  • No genetic test history for ARVC variants
  • Heart failure with severely reduced left ventricular ejection fraction (LVEF <35%)
  • For women: Pregnancy, breastfeeding, or intention to become pregnant during the study.
  • Known or suspected non-compliance, drug, or alcohol abuse
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant
  • Previous enrolment into the current study

Treatment and study plan

Exercise

Other

Participants will perform 3 min of the different activities, followed by a 10-min recovery window.

Other names: cycling, squats, biceps curls, walking

Primary outcomes

  1. count of premature ventricular beats during and after the activities

    Time frame: measured during the 3 min of activity and the 10 min of recovery

    count of premature ventricular beats during and after the activities

Secondary outcomes

  1. cardiac load during different activities, as rate-pressure product

    Time frame: measured during the 3 min of activity

    product of heart rate and systolic blood pressure

  2. cardiac load during different activities, as cardiac output

    Time frame: measured during the 3 min of activity

    product of heart rate and stroke volume, in L/min

  3. cardiac load during different activities, as peak blood pressure

    Time frame: measured during the 3 min of activity

    systolic blood pressure, in mmHg

Study contacts

Contact information is provided by the study sponsor or research team.

Christina M Spengler, PhD, MD

CONTACT

[email protected]

+41446325007

Fernando G Beltrami, PhD

CONTACT

[email protected]

+41446330472

Sponsors and collaborators

Lead sponsor

Swiss Federal Institute of Technology

Other

Collaborators

  • University of Zurich

Registry information

Official study title

Characterization of Arrhythmogenic Activity During and After Physical Exercise in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Sep 15, 2023
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.